Arvind Bhanushali of Yashraj Biotechnology, Raja Mugasimangalam of Genotypic Technology, Manikandan S A of Olympus Therapeutics, Mallikarjun Sundaram of Mitra Biotech, Dr. Shama Bhat of Bhat Biotech & Supreet Deshpande of NovaLead Pharma are in the race for the coveted Pharma Leaders Innovative Biotech Business Leader of the year 2018

Arvind Bhanushali of Yashraj Biotechnology, Raja Mugasimangalam of Genotypic Technology, Manikandan S A of Olympus Therapeutics, Mallikarjun Sundaram of Mitra Biotech, Dr. Shama Bhat of Bhat Biotech & Supreet Deshpande of NovaLead Pharma are in the race for the coveted Pharma Leaders Innovative Biotech Business Leader of the year 2018
Pharma Leaders Innovative Biotech Business Leader of the year 2018
1. Mr. Arvind K.Bhanushali,Founder Director, Chairman, Yashraj Biotechnology Ltd.
2. Mr. Raja Mugasimangalam,Founder & CEO, Genotypic Technology Pvt Ltd.
3. Mr. Manikandan S A, Managing Director, CEO, Olympus Therapeutics Pvt Ltd
4. Dr. Mallikarjun Sundaram,Co-Founder, President & CEO,Mitra Biotech.
5. Dr. Shama Bhat,Founder, Bhat Biotech India (P) Ltd.
6. Mr. Supreet Deshpande, Founder & Chairman, NovaLead Pharma Pvt. Ltd.
Voting Link : https://goo.gl/forms/mECUU0BaPL2Uqa3m2
Growing at a faster pace, in comparison with the previous years, the Indian biotech industry witnessed YoY growth of 57.14 per cent in FY16; the total industry size stood at US$ 11 billionby FY16 and is estimated to reach US$ 11.6 billion by FY17.Fast-paced growth is likely to continue; the industry is expected to increase in size to US$ 11.6 billion by 2017, driven by a range of factors such as growing demand, intensive R&D activities and strong government initiatives. The Indian biotech industry holds about 2 per cent share of the global biotech industry. The biotechnology industry in India, comprising about 800 companies, is expected to be valued at US$ 11.6 billion in 2017. Biopharma is the largest sector contributing about 62 per cent of the total revenue followed by bio-services (18 per cent), bio-agri (15 per cent), bio-industry (4 per cent), and bio-informatics contributing (1 per cent). The high demand for different biotech products has also opened up scope for the foreign companies to set up base in India. India has emerged as a leading destination for clinical trials, contract research and manufacturing activities owing to the growth in the bio-services sector. With 13.7 per cent contribution to the global pharmaceuticals and biotechnology workforce, India has emerged as the second largest market for the industry.

Ranked by Industry experts, Pharma Leaders is arguably the India’s largest & most trusted healthcare communication company specializing in executing high profile research findings, media broadcasting, healthcare campaigning & producing highly acclaimed world-class events once in a year .We are one of the very few global healthcare company with leadership positions in reaching out to the key sectors & stakeholders of pharmaceutical and life sciences, healthcare firms, hospitals, medical services, top notch opinion makers in the medical profession & other disciplines associated with healthcare industry. Pharma Leaders research findings are often cited at various credible places & the annual awards are most awaited prestigious, coveted & credible healthcare leadership awards conferred to the trendsetters & path-breaking companies. Unlike other companies, Pharma Leaders refuses to follow the traditional approach in reaching out to the final rankings based on false & ambiguous reports which deny the high performing companies, though small but rich in innovative practices & often ignored by the mainstream media & lost out to the biggies. The robust selection process at Pharma Leaders awards are a year long process where only innovations & out of box ideas triumph.